Literature DB >> 14578913

More evidence on blocking the renin-angiotensin-aldosterone system in cardiovascular disease and the long-term treatment of hypertension: data from recent clinical trials (CHARM, EUROPA, ValHEFT, HOPE-TOO and SYST-EUR2).

G Y H Lip1, D G Beevers.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14578913     DOI： 10.1038/sj.jhh.1001650

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN： 0950-9240            Impact factor:   3.012


× No keyword cloud information.
  5 in total

Review 1.  Atherosclerotic renal artery stenosis, ACE inhibitors, and avoiding cardiovascular death.

Authors:  John Main
Journal:  Heart       Date:  2005-04       Impact factor: 5.994

Review 2.  Pathways involved in the transition from hypertension to hypertrophy to heart failure. Treatment strategies.

Authors:  John W Wright; Shigehiko Mizutani; Joseph W Harding
Journal:  Heart Fail Rev       Date:  2007-11-07       Impact factor: 4.214

Review 3.  The role of angiotensin II type 1 receptor antagonists in elderly patients with hypertension.

Authors:  G Neil Thomas; Paul Chan; Brian Tomlinson
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

Review 4.  Reappraisal of role of angiotensin receptor blockers in cardiovascular protection.

Authors:  C Venkata S Ram
Journal:  Vasc Health Risk Manag       Date:  2011-05-15

Review 5.  Evolving treatment options for prevention of cardiovascular events in high-risk hypertensive patients.

Authors:  Prakash Deedwania
Journal:  J Clin Hypertens (Greenwich)       Date:  2007-11       Impact factor: 3.738
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.